Corrigendum to “High expression of mesothelin in plasma and tissue is associated with poor prognosis and promotes invasion and metastasis in gastric cancer” [Adv. Cancer Biol. – Metastasis 7 (2023) 100098]
Corrigendum to “High expression of mesothelin in plasma and tissue is associated with poor prognosis and promotes invasion and metastasis in gastric cancer” [Adv. Cancer Biol. – Metastasis 7 (2023) 100098]. // Computational Biology and Chemistry. – URL: https://www.sciencedirect.com/science/article/pii/S2667394026000481?dgcid=rss_sd_all
Corrigendum to “High expression of mesothelin in plasma and tissue is associated with poor prognosis and promotes invasion and metastasis in gastric cancer” [Adv. Cancer Biol. – Metastasis 7 (2023) 100098]. Computational Biology and Chemistry. https://www.sciencedirect.com/science/article/pii/S2667394026000481?dgcid=rss_sd_all
“Corrigendum to “High expression of mesothelin in plasma and tissue is associated with poor prognosis and promotes invasion and metastasis in gastric cancer” [Adv. Cancer Biol. – Metastasis 7 (2023) 100098].” Computational Biology and Chemistry.
@article{article11534,
title = {Corrigendum to “High expression of mesothelin in plasma and tissue is associated with poor prognosis and promotes invasion and metastasis in gastric cancer” [Adv. Cancer Biol. – Metastasis 7 (2023) 100098]},
journal = {Computational Biology and Chemistry},
url = {https://www.sciencedirect.com/science/article/pii/S2667394026000481?dgcid=rss_sd_all}
}
Publication date: November 2026 Source: SLAS Discovery, Volume 44 Author(s): David A. Close, Cynthia S. Hinck, Chang-Hyeock Byeon, Lukasz Wieteska, Andrew P. Hinck, Paul A. Johnston
Publication date: November 2026 Source: SLAS Discovery, Volume 44 Author(s): Thomas Hofstetter, Özlem Yavas Grining, Christophe Roubeix, Peter D. Westenskow, David A. Fluri